Cargando…
A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer.
Epidemiological and experimental evidence indicates that oestrogens are involved in the carcinogenic promotion of human breast cancer. We have undertaken a pilot trial of tamoxifen, an anti-oestrogen, compared to placebo given to 200 women at a high risk of developing breast cancer. The results of t...
Autores principales: | Powles, T. J., Hardy, J. R., Ashley, S. E., Farrington, G. M., Cosgrove, D., Davey, J. B., Dowsett, M., McKinna, J. A., Nash, A. G., Sinnett, H. D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247327/ https://www.ncbi.nlm.nih.gov/pubmed/2679843 |
Ejemplares similares
-
A randomised comparative trial of mitozantrone/methotrexate/mitomycin C (MMM) and cyclophosphamide/methotrexate/5 FU (CMF) in the treatment of advanced breast cancer.
por: Jodrell, D. I., et al.
Publicado: (1991) -
Duct carcinoma in situ: predictors of local recurrence and progression in patients treated by surgery alone.
por: Price, P., et al.
Publicado: (1990) -
Measurement of S-phase fraction and ploidy in sequential fine-needle aspirates from primary human breast tumours treated with tamoxifen.
por: Fernando, I. N., et al.
Publicado: (1994) -
Haemostatic changes and thromboembolic risk during tamoxifen therapy in normal women.
por: Jones, A. L., et al.
Publicado: (1992) -
BRCA1, BRCA2 and pedigree genetic analysis to determine genetic risk in the UK Royal Marsden Hospital tamoxifen prevention trial
por: Kote-Jarai, Z, et al.
Publicado: (2000)